|Bid||0.00 x 1000|
|Ask||0.00 x 1000|
|Day's Range||35.64 - 37.36|
|52 Week Range||17.99 - 41.85|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 08, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||36.36|
Joining me today are Shawn Morris, our chief executive officer; Parth Mehrotra, president, and chief operating officer; and David Mountcastle, our chief financial officer. This call is being webcast and can be accessed from the investor relations section of priviahealth.com.
Privia Health easily beat second-quarter expectations for revenue and practice collections, leading the IPO stock to soar Thursday.
Privia Health (PRVA) delivered earnings and revenue surprises of -400% and 7.53%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?